Pasar al contenido principal

SENESCENCIA CELULAR CEREBRAL COMO CONDICION ASOCIADA AL ENVEJECIMIENTO QUE AGRAVA EL DAÑO CEREBRAL INDUCIDO POR ICTUS: UNA OPORTUNIDAD PARA LOS FARMACOS SENOLITICOS

PID2020-119603RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA LA INVESTIGACION HOSPITAL UNIVERSITARIO LA FE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

The Senolytic Drug Navitoclax Protects the Brain After Experimental Ischemic Stroke

  • Falahatgaroshibi, Dianoush
  • Baixauli-Martin, Julia
  • Burguete, Maria C.
  • Lopez-Morales, Mikahela A.
  • Aliena-Valero, Alicia
  • Peris, Jose E.
  • Salom, Juan B.
[EN] Background/Objectives: Senescence has been recently described in brain cells following ischemic stroke. The potential of targeting senescence as an effective therapeutic approach in the treatment of ischemic stroke requires further investigation. This study evaluated the effects of the senolytic drug navitoclax after experimental ischemic stroke. Methods: Navitoclax was injected into male young Wistar rats at doses of 10 and 30 mg/kg (i.p.). to evaluate its pharmacokinetics, cerebral levels and potential to cause thrombocytopenia. Subsequently, a second group of rats underwent 60 min of transient middle cerebral artery occlusion (tMCAO). Navitoclax (10 mg/kg, i.p.) or vehicle was injected every other day between days 3 and 13 after tMCAO. Neurofunctional performance, infarct size, and senescence markers were assessed on day 14. Results: Navitoclax (10 mg/kg) administration resulted in a maximum plasma concentration of 0.702 mg/L and half-life of 11.33 h. Additionally, a brain concentration of 0.04 +/- 0.02 & micro;g/g was detected. Moderate thrombocytopenia was induced by 10 mg/kg, and to a greater extent by 30 mg/kg. Navitoclax (6 & times; 10 mg/kg) improved neurofunctional impairment, as indicated by significant decrease by 66% in the total time for the tape removal test, and significantly reduced infarct area by 52% when compared to vehicle. Moreover, navitoclax significantly reduced levels of SA-beta-gal (by 80%), lipofuscin (by 91%), and Checkpoint kinase 2 (Chk2; by 69%) in the ischemic hemisphere. Conclusions: Navitoclax protects the brain after ischemic stroke by improving neurofunctional outcome and reducing infarct size, which is associated with reducing senescence markers. Although moderate thrombocytopenia warrants caution, targeting senescence emerges as a promising therapeutic strategy for ischemic stroke., This research was funded by Ministerio de Ciencia e Innovacion (MICIU/AEI /10.13039/501100011033) grant PID2020-119603RB-I00 and by the Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital, grant CIAICO/2022/248.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Spatio-Temporal Characterization of Cellular Senescence Hallmarks in Experimental Ischemic Stroke

  • Baixauli-Martín, Júlia
  • Burguete, Mª Consuelo
  • López-Morales, Mikahela Andrea
  • Castelló, María
  • Aliena-Valero, Alicia
  • Jover, Teresa
  • Falahatgaroshibi, Dianoush
  • Torregrosa, Germán
  • Salom, Juan B.
[EN] In recent years, evidence of the existence of cellular senescence in the central nervous system has accumulated. In ischemic stroke, cellular senescence has been suggested as an unidentified pathophysiological mechanism, prompting research into the neuroprotective potential of senolytic drugs. This study aims to provide spatio-temporal evidence of the existence of brain senescence following ischemic stroke and to elucidate the involved pathways and cell types. We focused on the most established markers of senescence: cell cycle arrest (p16, p21); lysosomal activity (senescence-associated beta-galactosidase [SA-beta-gal]); the senescence-associated secretory phenotype ([SASP]; Interleukin-6 [IL-6], Interleukin-1 beta [IL-1 beta], Tumor necrosis factor [TNF]); and DNA/nuclear damage (Checkpoint kinase 1 [Chk1], Checkpoint kinase 2 [Chk2], Lamin B1 [LB1]). Male Wistar rats underwent 60 min of transient middle cerebral artery occlusion, followed by 24 h and 3, 7, and 14 days of recovery. Our results show significant increases in p16 expression, particularly in neurons and microglia/macrophages; SA-beta-gal accumulation in the infarcted tissue; significant increases in SASP markers as early as 24 h after reperfusion; and significant changes in Chk1, Chk2, and LB1 at 14 days. Overall, our findings lend support to the existence of senescence after ischemic stroke in neurons and microglia/macrophages. However, there is still room to gain further insight into the role of senescence in the pathophysiology of ischemic stroke and in the implementation of successful senolytic therapy., This research was funded by the Ministerio de Ciencia e Innovacion, grant number PID2020-119603RB-I00; by the Instituto de Salud Carlos III, grant number RD21/0006/0014 (co-funded by European Regional Development Fund "A way to make Europe"); and by the Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital, grant number CIAICO/2022/248.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fermented Lignan-Enriched Soy Beverage Ameliorates the Metabolic Effects of a High-Fat Diet on Female Mice

  • Ruiz de la Bastida, Ana
  • Langa, Susana
  • Peirotén, Ángela
  • Curiel, José Antonio
  • Fernández-González, Raúl
  • Maroto, María
  • Arqués, Juan
  • Gutiérrez-Adán, Alfonso
  • Landete, José María
Fermented vegetable beverages have potential beneficial effects on the health associated with the production of bioactive flavonoids and lignans by selected bacterial strains. Here, we studied the effects of a soy beverage and a soy beverage fermented by Bifidobacterium pseudocatenulatum INIA P815, both supplemented with lignan extracts, in a female mouse model on a high-fat diet followed for 16 weeks. The high-fat diet induced an increase in adipose tissue and plasma cholesterol as well as modified the fecal microbiota. Mice groups receiving any of the beverages showed a reduction in the mean area of ovarian fat tissue adipocytes and exhibited bioactive flavonoids and lignans in plasma and tissues, accompanied by a higher antioxidant activity in plasma. The group of mice subjected to the fermented beverage also demonstrated a lower increase in plasma cholesterol levels, an increase in short-chain fatty acid production, and higher levels of daidzein, genistein, enterolignans, and herbacetin in the plasma and organs. Moreover, the fertility of the mice that received the fermented beverage was also enhanced, resulting in a higher percentage of blastocysts per female mouse. Therefore, the consumption of the beverage fermented by B. pseudocatenulatum INIA P815 could be favoring the health of mice by ameliorating, to some extent, the effects of a high-fat diet., This work was supported by Project PID2020-11960RB-I00 from the Spanish Ministry of Science and Innovation. Ana Ruiz de la Bastida is a recipient of a pre-doctoral contract (PRE2018-086293). The authors are grateful to the Institute of Food Science, Technology and Nutrition (ICTAN, Madrid, Spain) Analysis Services Unit for providing chromatography and mass spectrometry facilities., Peer reviewed